Alterations in the development of a M2 phenotype in glial cells: rotenone in vitro model of Parkinson's disease
Year: 2017
Type: article
Abstract: Parkinson’s disease is a chronic, progressive, disabling neurodegenerative disease \nof unknown cause. It turned out to be the second most common neurodegenerative \ndisorder after Alzheimer Disease, and is characterized by motor and non-motor \nsymptoms. As a multifactorial disease, it is characterized by dopaminergic \ndegeneration, depositions of α-synuclein aggregates, and to run with an inflammatory \nprocess. The involvement of microglial cells on this chronic inflammation within the \nparenchyma is long accepted but its role is not fully understood. Both genetic and \nenvironmental factors have been postulated to play a role in the development of \nParkinson’s disease. Epidemiological studies show that the exposition to certain toxins, \namong them rotenone, is a risk factor to develop this neurodegenerative disease. \nAlthough the neurotoxic effect of rotenone has been widely studied in experimental \napproaches, the effect of rotenone on glial cells remains poorly characterized. The \npresent work was aimed to study whether rotenone induced the expression of M2 \nmarkers in glial cells, and also whether rotenone interfered with the development of a \nM2 phenotype induced by Interleukin-4 in glial cells, using primary glial cultures. The \nresults obtained reveal that rotenone did not induce the expression of M2 markers in \nglial cells per se. However, it dramatically inhibited the development of a M2 \nphenotype induced by Interleukin-4 in mixed glial cell cultures. On the contrary, \nrotenone did not modify Interleukin-4 – induced M2 phenotype in microglial cell \ncultures, suggesting the existence of alternative mechanisms to obtain energy of \nmicroglial cell cultures. However, phagocytic activity was impaired in microglial cell \ncultures. The results obtained suggest that rotenone impairs the immune response of \nglial cells and that glial cell dysfunction due to a direct action of certain toxins on glial \ncells may contribute to the development of neurodegeneration in PD.
Author: Lucas Blasco-Agell
Language: English
Subfield: Neurology
Field: Neuroscience
Domain: Life Sciences
Open Access status: green
OpenAlex ID: W2939480373
